Hal will be stopped for maintenance from friday on june 10 at 4pm until monday june 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Differential regulation of TNFα, IL-1β, IL-6, IL-8, TNFβ, and IL-10 by pentoxifylline

Abstract : Pentoxifylline (PTX) is a methylxanthine drug known to inhibit the production of tumor necrosis factor-alpha (TNFα), which plays a key role in inflammation. Recent studies also revealed that other cytokines may be inhibited by PTX. We investigated PTX effects on production and mRNA expression of TNFα, IL-1β, IL-6, IL-8, TNFβ and IL-10. Cytokine release was studied in 1/10 diluted whole blood culture (WB) and in peripheral blood mononuclear cell (PBMC) culture. Cytokine production was triggered in both culture systems by endotoxin (LPS) or by phorbol ester (PMA) plus phytohemagglutinin (PHA). Our results showed that expression and production of TNFα and TNFβ were inhibited by PTX in a dose-dependent manner. Moreover, we observed that depending on the way of activating cells, PTX induced an up- or a down-regulation (in PMA+PHA or LPS stimulated cells, respectively) for IL-1 and IL-6 release. We also noted that the effects of PTX on IL-6, IL-8 and IL-10 production were different in WB and in PBMC culture. In conclusion PTX acts on cytokine in a complex manner depending on cellular environment and on the method of activation.
Document type :
Journal articles
Complete list of metadata

https://hal.univ-reunion.fr/hal-02303116
Contributor : Réunion Univ Connect in order to contact the contributor
Submitted on : Wednesday, October 2, 2019 - 8:53:05 AM
Last modification on : Thursday, April 7, 2022 - 10:10:37 AM

Links full text

Identifiers

Collections

Citation

Christian Lefebvre d'Hellencourt, Léna Diaw, Pascale Cornillet, Moncef Guenounou. Differential regulation of TNFα, IL-1β, IL-6, IL-8, TNFβ, and IL-10 by pentoxifylline. International Journal of Immunopharmacology, Elsevier, 1996, 18 (12), pp.739-748. ⟨10.1016/S0192-0561(97)85556-7⟩. ⟨hal-02303116⟩

Share

Metrics

Record views

35